FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

IntegraDose Compounding Services Vasopressin 2 Units/2 mL in 0 Recall

Vasopressin 2 Units/2 mL in 0

IntegraDose Compounding Services LLC · Minneapolis, MN

Risk level
Class II
Reported by FDA
Feb 21, 2024
Recall ID
D-0325-2024
Check your lot numberHow we source this data

Summary

IntegraDose Compounding Services recalled Vasopressin 2 Units/2 mL in 0 starting Jan 22, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0325-2024 on Feb 21, 2024. Reason: Sub-potent drug: failure to maintain potency through the duration of the labeled expiration/beyond-use date. Status: Ongoing.

Why it was recalled

Sub-potent drug: failure to maintain potency through the duration of the labeled expiration/beyond-use date.

Product description

Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride Sterile Syringe for Injection, Concentration: 1 Unit/mL, 2 mL Syringe, Rx Only, 719 Kasota Ave SE, Minneapolis, MN, Compounded Drug Not for Resale. Office Use Only, NDC 71139-0190-1.

Lot numbers, UPCs & expiration codes

Lot #s: 20230929VAS-2, Exp. 02/29/2024; 20231004VAS-2, Exp. 04/01/2024; Lot 20231010VAS-2,Exp. 04/07/2024; Lot 20231013VAS-2, Exp. 04/10/2024

Where it was sold

MN

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0325-2024
Classification
Class II
Status
Ongoing
Recall initiated
Jan 22, 2024
FDA report date
Feb 21, 2024
Quantity
1,299 syringes
Recall type
Voluntary: Firm initiated
Recalling firm
IntegraDose Compounding Services LLC

Original FDA data

Every field from FDA enforcement report D-0325-2024, exactly as published.

Show all FDA fields
City
Minneapolis
State
MN
Status
Ongoing
Country
United States
Event ID
93940
Address
719 Kasota Ave Se
Code information
Lot #s: 20230929VAS-2, Exp. 02/29/2024; 20231004VAS-2, Exp. 04/01/2024; Lot 20231010VAS-2,Exp. 04/07/2024; Lot 20231013VAS-2, Exp. 04/10/2024
Postal code
55414-2842
Report date
Feb 21, 2024
Product type
Drugs
Recall number
D-0325-2024
Classification
Class II
Recalling firm
IntegraDose Compounding Services LLC
Product quantity
1,299 syringes
Reason for recall
Sub-potent drug: failure to maintain potency through the duration of the labeled expiration/beyond-use date.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride Sterile Syringe for Injection, Concentration: 1 Unit/mL, 2 mL Syringe, Rx Only, 719 Kasota Ave SE, Minneapolis, MN, Compounded Drug Not for Resale. Office Use Only, NDC 71139-0190-1.
Distribution pattern
MN
Recall initiation date
Jan 22, 2024
Initial firm notification
Letter
Center classification date
Feb 15, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0325-2024, published Feb 21, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls